Hellen Siwanowicz
Patrimonio netto: 26 000 $ in data 31/08/2026
Patrimonio netto: 26 000 $ in data 31/08/2026
Hellen Siwanowicz is currently an Independent Director at Gold Terra Resource Corp.
since 2020 and a Director at Billy Bishop Toronto City Airport.
Former positions include Director at Lang Michener LLP from 1996 to 2016 and Independent Director at Waverley Pharma, Inc. from 2017 to 2023.
Education includes graduate studies at the University of Toronto.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/08/2026 | 200.000 ( 0,04% ) | 26 000 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GOLD TERRA RESOURCE CORP. | Direttore/Membro del Consiglio | 11/08/2020 |
Billy Bishop Toronto City Airport
Billy Bishop Toronto City Airport Other TransportationTransportation Operates as an airport | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| WAVERLEY PHARMA INC. | Direttore/Membro del Consiglio | 22/11/2023 |
Lang Michener LLP
Lang Michener LLP Miscellaneous Commercial ServicesCommercial Services Provides legal advisory services | Direttore/Membro del Consiglio | 01/01/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Gold Terra Resource Corp.
Gold Terra Resource Corp. Precious MetalsNon-Energy Minerals Explores and develops natural resource properties | Non-Energy Minerals |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lang Michener LLP
Lang Michener LLP Miscellaneous Commercial ServicesCommercial Services Provides legal advisory services | Commercial Services |
Billy Bishop Toronto City Airport
Billy Bishop Toronto City Airport Other TransportationTransportation Operates as an airport | Transportation |
Waverley Pharma, Inc.
Waverley Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale